U.S. Sen. Tina Smith: Federal Judge’s Decision Threatens Vital Health Care Coverage for Millions of Americans
WASHINGTON, D.C. [12/14/18]—Today, U.S. Senator Tina Smith (D-Minn.) released the following statement after a federal judge in Texas deemed provisions of the landmark Affordable Health Care
U.S. Senator Tina Smith Continues Fight to Lower Prescription Drug Prices By Backing Bipartisan Legislation to Bring Generics to Market
Senator Says Bipartisan Legislation Would Combat Brand-Name Pharmaceutical Companies Unfairly Blocking Lower-Cost Generic Drugs WASHINGTON, D.C [02/06/2019]—This week, U.S. Senator Tina Smith (D-Minn.) continued one
U.S. Senators Klobuchar, Smith Push to Prevent Unfair Prescription Drug Hikes
Senators Back Bill to Stop Big Pharma from Using Exclusivity Periods to Stave Off Lower-Cost Generics Coming to Market WASHINGTON, D.C. [02/07/2019]—U.S. Senators Amy Klobuchar
U.S. Sens. Smith, Durbin, Cramer, Cassidy’s Call to FDA: Price of Insulin is “Unacceptable” and Action is Needed to Bring Generics to Market
Senators Urge FDA to Revise Recent Policy Changes That Would Prevent Lower-Cost Insulin Products From Coming to Market WASHINGTON, D.C. [03/04/2019]—U.S. Senators Tina Smith (D-Minn.),
U.S. Sens. Tina Smith, Jerry Moran Reintroduce Bill to Make Life-saving Oral Cancer Medications More Affordable
Senators’ Reintroduce Legislation to Ensure Oral Cancer Drugs are Covered in Same Way as Traditional IV Chemotherapy WASHINGTON, D.C. [03/12/19]—Today, U.S. Sens. Tina Smith (D-Minn.)
English